GWAMA: software for genome-wide association meta-analysis.
Mägi R, Morris AP. · 2010
Read GWAMA: software for genome-wide association meta-analysis. by Mägi R, Morris AP. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc2893603.txt.
Introduction
Mägi and Morris released in 2010 GWAMA, open-source software for pooling genome-wide association studies into one larger analysis. Single studies often lack the sample size to catch genes with small effects on traits like diabetes or obesity. Combining summary results across studies, called meta-analysis, raises that power, but genome-scale files strain ordinary statistics packages.
GWAMA handles the scale with built-in error trapping that catches mismatched strands, alleles, and file formats before they corrupt results. It computes the standard pooled effect measures for both yes-no traits and measured traits, under models that allow effects to vary between studies. Companion scripts format each study's output and draw genome-wide summary plots. The package made rigorous pooling routine for the consortia era of genetics.
Catalog record
| CREATOR | Mägi R, Morris AP. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
GWAMA: software for genome-wide association meta-analysis By Reedik Mägi, Andrew P Morris Published in: BMC Bioinformatics DOI: 10.1186/1471-2105-11-288 ABSTRACT Abstract Background Despite the recent success of genome-wide association studies in identifying novel loci contributing effects to complex human traits, such as type 2 diabetes and obesity, much of the genetic component of variation in these phenotypes remains unexplained. One way to improving power to detect further novel loci is through meta-analysis of studies from the same population, increasing the sample size over any individual study. Although statistical software analysis packages incorporate routines for meta-analysis, they are ill equipped to meet the challenges of the scale and complexity of data generated in genome-wide association studies. Results We have developed flexible, open-source software for the meta-analysis of genome-wide association studies. The software incorporates a variety of error trapping facilities, and provides a range of meta-analysis summary statistics. The software is distributed with scripts that allow simple formatting of files containing the results of each association study and generate graphical summaries of genome-wide meta-analysis results. Conclusions The GWAMA (Genome-Wide Association Meta-Analysis) software has been developed to perform meta-analysis of summary statistics generated from genome-wide association studies of dichotomous phenotypes or quantitative traits. Software with source files, documentation and example data files are freely available online at http://www.well.ox.ac.uk/GWAMA. BACKGROUND Genome-wide association (GWA) studies of hundreds of thousands of single nucleotide polymorphisms (SNPs), genotyped in samples of thousands of individuals, such as those undertaken by the Wellcome Trust Case Control Consortium [1], have proved successful in identifying novel common variants contributing moderate effects to a wide range of complex human traits (odds ratios greater than 1.2 for dichotomous traits or heritability of at least 1% for quantitative phenotypes). However, much of the genetic variation underpinning variation in these traits remains, as yet, unexplained. One natural way to increase power to detect rarer variants of more modest effect is to increase sample size. This can most readily be achieved through meta-analysis of multiple studies from the same or closely related populations, increasing the sample size to the order of tens of thousands. Such analyses have led to the identification of multiple, now established associations that would not otherwise have been identified in any individual study [2-4]. Meta-analysis of GWA studies has been greatly assisted by the development of imputation techniques [5,6] which predict genotypes not directly typed on available GWA genotyping products, but which are present on a dense reference panel of haplotypes, such as those available as part of the International HapMap Project [7] or the 1,000 Genomes Project [8]. With this approach, the results of GWA studies can be combined through meta-analysis of millions of SNPs, even if samples are interrogated with different GWA genotyping products. The statistical methodology underlying meta-analysis is already well established [9], and freely available software packages provide routines for its implementation [10]. However, in the context of GWA studies, we face a number of unique challenges that make these existing tools impractical: (i) results are often combined for many studies for millions of SNPs, thus requiring memory efficient data manipulation; (ii) there may be over-dispersion of GWA test-statistics due to population structure, and between study variation, both of which must be accounted for in the meta-analysis; and (iii) computational difficulties in combining results obtained using different GWA genotyping products which may be aligned to different strands. To address these challenges, we have developed the GWAMA (Genome-Wide Association Meta-Analysis) software to perform meta-analysis of summary statistics generated from GWA studies of dichotomous phenotypes or quantitative traits. The software incorporates tools to align studies to the same reference strand, irrespective of the GWA genotyping product, where possible, and optionally performs genomic control [11] of summary statistics to correct for population structure within each study, and potential variation between studies. The software also incorporates scripts for the generation of summaries of genome-wide meta-analyses including Manhattan and quantile-quantile (QQ) plots. Here, we demonstrate application of the GWAMA software to meta-analysis of 5 GWA studies, typed using different GWA genotyping products, but imputed at more than 2.3 million SNPs present on the International HapMap Project reference panels [7]. There are already several software packages available for meta-analysis and therefore comparison with some of the most widely used programs is part of current study. IMPLEMENTATION Consider a meta-analysis of N GWA studies, not necessarily typed using the same genotyping product or imputed to the same reference panel. We assume that studies have been filtered for appropriate quality control metrics to exclude poorly genotyped or imputed SNPs [12]. For each study, the following information is required for each good quality SNP: (i) the marker identifier; (ii) the allelic effect estimate and corresponding standard error (or an allelic odds ratio and 95% confidence interval in the case of a dichotomous trait); and (iii) the allele for which the effect has been estimated and the complimentary non-reference allele. Optionally, users may provide: (i) the frequency of the reference allele and the strand to which it has been aligned, which may aid alignment of AT/GC SNPs; (ii) the sample size contributing to the effect estimate; and (iii) an indicator to identify if the SNP has been directly genotyped in the study or imputed from a reference panel. GWAMA begins by aligning all studies to the same reference allele at each SNP. If strand information is provided, a log file records potential misalignments and any corrections made based on the provision of reference alleles. Fixed effects meta-analysis is then performed for each SNP by combining allelic effects weighted by the inverse of their variance. The software performs tests of heterogeneity of effects across studies, and reports simple summaries of the direction of their effect in each to highlight potential inconsistencies in results. In the presence of heterogeneity of effects between studies, GWAMA can perform random-effects meta-analysis for each SNP by calculating the random-effects variance component. Graphical summaries of the results of the meta-analysis can be generated using the output of GWAMA, in conjunction with accompanying R scripts [10], provided that a map file containing SNP identifiers, chromosome and location are specified. A dense map file is provided with the GWAMA software which includes SNPs incorporated on a wide range of GWA genotyping products and variants present on the Phase 2 HapMap reference panel [7]. File formatting prior to meta-analysis GWAMA is distributed with PERL scripts to format output from GWA association tools including PLINK [13] and SNPTEST [14]. The scripts extract the appropriate summary statistics from the output of these analysis packages, and allow subsequent filtering of results to exclude SNPs on the basis of minor allele frequency and/or number of called genotypes. However, we assume that studies have been otherwise filtered for appropriate quality control metrics to exclude poorly genotyped or imputed SNPs [12]. Study alignment and error trapping GWAMA initially checks input data files for errors, such as negative values for odds ratios, and reports any issues to the log file. The study is then excluded from the meta-analysis for that SNP. The reference allele reported in the first study for each SNP is taken as reference, to which all allelic effects are then aligned (Table 1). If studies include estimates of the reference allele frequency, large discrepancies